Entvantage Dx is an innovative in-vitro diagnostics company that specializes in providing rapid, in-office diagnostic tests to Primary Care Physicians and Otolaryngologists. Their state-of-the-art tests help determine the cause of ear, nose, and throat illnesses, enabling healthcare professionals to make more accurate diagnoses and provide targeted treatments. Led by a team of experienced professionals, including CEO Joe Skraba and Director of Assay Development Oriana Hawkins, PhD, Entvantage Dx brings together a wealth of knowledge and expertise.

With over 30 years of experience in commercialization and sales of medical devices, Joe Skraba has a proven track record of success. He has engineered and developed products that have achieved sales of more than $5 billion and has recently secured significant venture funding for various organizations. Meanwhile, Dr.

Oriana Hawkins has over 19 years of research experience, specializing in immunoassay development and preclinical models of drug efficacy. Her expertise in microbiology and immunology adds tremendous value to the development of innovative diagnostic tests. In summary, Entvantage Dx is dedicated to revolutionizing the field of in-vitro diagnostics, providing cutting-edge solutions that empower healthcare professionals to deliver efficient and accurate care